Resources
Find the publications relevant to your drug development programs.
Drug Type
- Small Molecule/Tyrosine Kinase Inhibitors
- Adoptive Cell Therapies
- Antibody Dependent Cellular Cytotoxicity
- Checkpoint Inhibitors
- Antibody Drug Conjugates
- Other
Cancer Type
- NSCLC
- HNSCC
- Renal
- Colorectal
- Bladder
- Other
Need Help?
Contact Us for support
Oct 21, 2020
An ex vivo tumoroid model of fresh patient tumors (3D-ACTSM) to assess efficacy of cellular therapy in immuno-oncology
Oct 21, 2020
Determining the efficacy of ADCC by the 3D-EXSM ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
Oct 21, 2020
Evaluating the effectiveness of targeting ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing
Oct 21, 2020
Assessing the impact of cGAS-STING pathway activation on adoptive cell therapy using a patient-derived 3D ex vivo tumor organoid model
Jun 22, 2020
A novel ex vivo 3D tumor organoid model of fresh patient tumors (3D-ACT) to assess efficacy of cellular therapy in immune-oncology
